期刊文献+

埃他卡林片对缺氧性肺动脉高压自由基代谢的影响 被引量:3

Effect of Iptkalim on free radicals metabolism in patients with hypoxic pulmonary hypertension
下载PDF
导出
摘要 目的:研究埃他卡林对缺氧性肺动脉高压(HPH)患者自由基代谢的影响。方法:在海拔5000 m以上高原,将110名HPH患者随机分为埃他卡林治疗组(实验组,n=74)和安慰剂对照组(n=36)。治疗前、治疗6个月后分别采血检测超氧化物歧化酶(SOD)、丙二醛(MDA)、一氧化氮(NO)及一氧化氮合酶(NOS)的含量。结果:服药前实验组较对照组SOD、MDA、NO、NOS无统计学差异(P>0.05);服药6个月后实验组较对照组SOD、NO、NOS增高,MDA降低,差异有统计学意义(P<0.05)。结论:氧自由基参与了HPH的发生发展过程,埃他卡林减轻脂质过氧化反应,是对HPH发挥保护作用的重要机制。 Objective:To explore the effects of Iptkalim on free radicals metabolism in patients with hypoxic pul- monary hypertension (HPH). Methods: A total of 110 cases of HPH who stayed at the altitude of 5000 m above were randomly divided into Iptkalim group (experimental group, n = 74) and placebo group (n = 36). Contents of SOD, MDA, NO and NOS in blood were detected before and 6 months after treatment. Results:No statistical differences were found in contents of SOD, MDA, NO and NOS between the two groups before the treatment (P 〉 0.05). The contents of SOD, NO and NOS increased and the contents of MDA decreased significantly in experi- mental group 6 months after treatment compared with that in placebo group ( P 〈 0.05 ). Conclusion: Oxygen free radicals are implicated in the pathogenesis of HPH. Iptkalim play a protective role through reducing the lipid perox- ide reaction.
出处 《西北国防医学杂志》 CAS 2012年第3期204-206,共3页 Medical Journal of National Defending Forces in Northwest China
基金 国家重大新药保密专项(2008ZXJ09004-018/50) 高原医学教育部重点实验室资助项目(2011JSGY05) 军区"十一五"攻关项目(08G081)
关键词 高原 缺氧性肺动脉高压 埃他卡林 自由基代谢 High altitude Hypoxic pulmonary hypertension Iptkalim Free radicals metabolism
  • 相关文献

参考文献9

  • 1Jeffery TK, Wanstall JC. Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension [ J ]Pharmacol Thera Peutics ,2001,92 : 1 - 20.
  • 2Hal Wang. Pharmacological characleristics of the novel an/i- hypertensive drug ipta.kalim hydrochloride and its molecular mechanisms[ J ]. Drug Dev Res ,2002,54:240 - 241.
  • 3中华人民共和国国家卫生部职业卫生标准GBZ92-2008[S].职业性高原病诊断标准,人民卫生出版社.2008.
  • 4Wang H,Tang Y,Zhang YL. Hypoxic pulmonary hypertension and iptakalim, a novel ATP sensitive potassium channel o- pener targeting smaller arteries in hypertension [ J ]. Cardio- vascr Drug Rev,2005,23(4) :293 -316.
  • 5Zhu HL, Luo WQ, Wang H. Iptakalim protects against hy- poxic brain injury through nmltiple pathways associated with ATP sensitive potassium channels [ J]. Neuroscience,2008, 157 (4) : 884 - 894.
  • 6Chen X, Gillis CN. Effects of free radicals on pulmonary vas- cular response to acetylcholine [ J ].J Appl Physiol, 1991,71(3) : 821 -825.
  • 7Mansoor AM, Honda M, Saida K, et al. Endothelin induced collagen remodeling in experimental pulmonary hypertension [ J]. Biochem Biophys Res Commun, 1995,215 ( 3 ) : 981 - 986.
  • 8Yuan XJ,Tod ML, Rubin LJ, et al. Inhibition of cytochrome P450 reduces vohagegated K + currents in pulmonary arterial myocytes [ J ]. Am J Physiol, 1995, 268 ( Ptl ) : C259 - 270.
  • 9贾国栋,刘国树,汪海.盐酸埃他卡林对血管内皮细胞分泌功能的影响[J].中国临床药理学与治疗学,2004,9(4):382-385. 被引量:7

二级参考文献8

  • 1[1]Wang H. Pharmacological characteristics of the novel antihypertensive drug iptakalim hydrochloride and its molecular mechanisms[J].Drug Dev Res,2003;58(1):65-8
  • 2[4]Bachetti T, Morbidelli L. Endothelial cells in culture: A model for studying vascular functions [J]. Pharmacol Res, 1999;42(1) :9 - 19
  • 3[5]Taddei S, Virdis A, Ghiadoni L, Sudano I, Salvetti A. Endothelial dysfunction in hypertension[ J]. J Cardiovasc Phannacol,2001 ;38(2): S11 - 4
  • 4[6]Taddei S, Virlis A,Ghiadoni L, Salvetti A. Vascular effects of endothelin-1 in essential hypertension: relationship with cyclooxygenase-derived endothelium-dependent contracting factors and nitric oxide[J]. J Cardiovasc Phannacol, 2000;35(4 Suppl 2):S37 - 40
  • 5[7]White R, Hiley CR. Hyperpolarisation of rat mesenteric endothelial cells by ATP-sensitive K( + ) channel openers[J]. Eur J Pharmacol, 2000; 397(2 - 3): 279 - 90
  • 6[8]Hardy P, Abran D, Hou X, Lahaie I, Peri, KG, Asselin P, et al. A major role for prostacyclin in nitric oxide-induced ocular vasorelaxation in the piglet[J]. Circ Res, 1998;83(7) :721 - 9
  • 7[9]Langheinrich U, Mederos Y, Schnitzler M, Daut J. Ca2+ -transients induced by K + channel openers in isolated coronary capillaries[J]. Pflugers Arch, 1998;435(3) :435 - 8
  • 8龙超良,肖文彬,汪海.盐酸埃他卡林的降压作用及对高血压血管重构的影响[J].高血压杂志,2003,11(3):248-250. 被引量:25

共引文献6

同被引文献24

  • 1王虹,王祥,解卫平.埃他卡林对低氧性肺动脉高压肺组织增殖细胞核抗原表达的抑制作用[J].医药导报,2005,24(1):7-9. 被引量:4
  • 2汪海,龙超良,贾国栋,何华美,解卫平,冯华松,胡刚,刘国树.盐酸埃他卡林对内皮素系统的影响[J].中国药理学通报,2005,21(1):33-38. 被引量:11
  • 3陶清国.肺血管结构改建、平滑肌细胞增生与原癌基因[J].国外医学(呼吸系统分册),1997,17(1):22-24. 被引量:8
  • 4高杉,龙超良,王汝欢,等.埃他卡林对压力超负荷大鼠心血管重构的逆转作用及其可能的内皮机制[c].第九届全国心血管药理学术会议论文集,2007.
  • 5Wang H. Pharmacological characteristics of the novel antihypertensive drug, iptakalim hydrochloride and its molecular mechanisms[J]. Drug Development Research, 2003, 58(1): 65-68.
  • 6Li J, Long C, Cui W, et al. Iptakalim ameliorates monocrotaline- induced pulmonary arterial hypertension in rats[J]. J Cardiovasc Pharmacol Ther, 2013, 18(1): 60-69.
  • 7Wang H, Zhang YL, Tang XC, et al. Targeting ischemie stroke with a novel opener of ATP-sensitive potassium channels in the brain[J]. Mol Pharmacol, 2004, 66(5): 1160-1168.
  • 8解卫平,崔文玉,龙超良,等.埃他卡林对肺动脉高压的影响及其作用机制研究[c].第九届全国心血管药理学术会议论文集,2007.
  • 9方翼,裴斐,王睿,等.中国健康成年志愿者单次口服盐酸埃他卡林片的安全性、耐受性研究[c].第十一次全国临床药理学学术大会论文集,2008:176-178.
  • 10Cai Y, Chai D, Pei F, et al. Single-dose pharmacokinetics and safety of iptakalim hydrochloride in Chinese healthy volunteers[J]. J Pharm Pharmacol, 2012, 64(3): 337-343.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部